In response to nutrient deficiency, eukaryotic cells activate macroautophagy, a degradative process in which proteins, organelles and cytoplasm are engulfed within unique vesicles called autophagosomes. Fusion of these vesicles with the endolysosomal compartment leads to breakdown of the sequestered material into amino acids and other simple molecules, which can be used as nutrient sources during periods of starvation. This process is driven by a group of autophagy-related (Atg) proteins, and is suppressed by TOR (target of rapamycin) signalling under favourable conditions. Several distinct kinase complexes have been implicated in autophagic signalling downstream of TOR. In yeast, TOR is known to control autophagosome formation in part through a multiprotein complex containing the serine/threonine protein kinase Atg1. Recent work in Drosophila and mammalian systems suggests that this complex and its regulation by TOR are conserved in higher eukaryotes, and that Atg1 has accrued additional functions including feedback regulation of TOR itself. TOR and Atg1 also control the activity of a second kinase complex containing Atg6/Beclin 1, Vps (vacuolar protein sorting) 15 and the class III PI3K (phosphoinositide 3-kinase) Vps34. During autophagy induction, Vps34 activity is mobilized from an early endosomal compartment to nascent autophagic membranes, in a TOR-and Atg1-responsive manner. Finally, the well-known TOR substrate S6K (p70 ribosomal protein S6 kinase) has been shown to play a positive role in autophagy, which may serve to limit levels of autophagy under conditions of continuously low TOR activity. Further insight into these TOR-dependent control mechanisms may support development of autophagy-based therapies for a number of pathological conditions.
Introduction
The TOR proteins were identified in 1991 by Hall and colleagues as direct targets of an antifungal rapamycin-FKBP (FK506-binding protein) complex, and were shown to be essential for progression through the G 1 -phase of the cell cycle [1] . Subsequent studies have identified a wide range of additional TOR (target of rapamycin)-dependent cellular processes, including cap-dependent translation, transcription, nutrient transport, endocytosis, glycogen accumulation and autophagy [2, 3] . Studies over the last 10 years have led to the concept of TOR complexes acting as a critical nodal point in a signalling network that regulates multiple cellular processes in response to nutrient conditions and several other inputs. A central challenge in this field is to understand the different roles each of these processes plays in mediating TOR-dependent effects on cell growth, metabolism and aging. In addition, we are only beginning to understand how these different processes interact and the molecular mechanisms of their regulation.
The degradative process known as autophagy is closely linked to the role of TOR in nutrient sensing and uptake [4, 5] . Under nutrient-poor conditions, decreased TOR activity results in removal of nutrient transporters from the cell surface, leading to a further decrease in available nutrients [6] . This loss of external nutrient supply is compensated for by increased production of nutrients from intracellular stores via autophagy. This catabolic process proceeds at a basal rate in nearly all eukaryotic cells, providing a self-renewal function that appears to be especially important in long-lived highly active cells such as neurons [7] . Nutrient, oxidative and energetic stresses result in a marked induction of autophagy in most cell types, and this plays a key role in cell survival under stressful conditions. The central role of TOR as an autophagy regulator in response to these diverse inputs has led to keen interest in the mechanisms by which TOR signalling suppresses autophagy. Recent studies in this area have identified a number of key downstream targets, and have revealed a surprising level of complexity involving both positive-and negative-feedback signalling.
Induction of autophagosome formation by
Atg1 (autophagy-related gene) 1/Ulk1 (Unc51-like kinase 1) complexes Genetic studies in yeast have identified approx. 30 Atg genes, which play essential roles in autophagy and autophagyrelated processes such as pexophagy and cytoplasm-tovacuole targeting of vacuolar hydrolases [8, 9] . The products of these genes act at discrete steps in autophagosome formation. Among the earliest acting of the Atg components is a protein kinase complex consisting of Atg1, Atg13 and Atg17. Studies in Saccharomyces cerevisiae found that TORdependent phosphorylation of Atg13 prevents assembly of this complex under growth conditions [10] [11] [12] [13] . Loss of TOR activity leads to dephosphorylation of Atg13, complex assembly and activation of Atg1 kinase activity. Interestingly, some Atg1 functions, such as recycling of certain Atg proteins, are independent of Atg1 kinase activity, implying an additional structural role for Atg1 [14, 15] .
Orthologues of Atg1 have also been shown to be essential for autophagy induction in higher eukaryotes. Null mutations in the Drosophila Atg1 gene cause a cell-autonomous defect in autophagosome formation in response to starvation, rapamycin treatment or developmental cues [16] . Similarly, dsRNA (double-stranded RNA)-mediated knockdown of the mammalian Atg1 orthologue Ulk1 (Unc51-like kinase 1) inhibits autophagy induction in human embryonic kidney cells [17] . Interestingly, autophagy is not disrupted in MEF (mouse embryonic fibroblast) cells harbouring a complete knockout of Ulk1, probably reflecting redundancy with the related Ulk2 gene in some genetic backgrounds [18] . Expression of kinase-defective versions of Ulk1, Ulk2 or Drosophila Atg1 cause an autophagy block, presumably through a dominant-negative mechanism [16, 17, 19] .
Given the conserved function of Atg1 orthologues, is the TOR-mediated regulation of these proteins conserved as well? Overexpression of Drosophila Atg1 leads to induction of autophagy in well-fed animals, indicating that high Atg1 levels can be sufficient to bypass TOR-dependent repressive signalling [20] . This function of Atg1 is inhibited by increased expression of Rheb or loss-of-function mutations in TSC2 (tuberous sclerosis complex 2), conditions that lead to TOR activation, consistent with the idea that TOR signalling suppresses Atg1 activity. Although characterization of Atg13 and Atg17 orthologues has not yet been reported, Mizushima and colleagues recently described the mammalian FAK (focal adhesion kinase)-interacting protein FIP200 as playing a role analogous to that of Atg17 [19] . This protein interacts with Ulk1 and promotes its stability and kinase activity. Atg13-related proteins have also recently been identified in metazoans [21] , and we have found that the Drosophila orthologue is essential for autophagy induction downstream of TOR, and that it binds to and regulates the TORdependent phosphorylation and activity of Atg1 (Y.-Y. Chang and T.P. Neufeld, unpublished work). Thus the basic framework of signalling from TOR to Atg1 appears to have been largely retained from single to multicellular organisms, making this perhaps the most conserved output of TOR signalling identified to date.
Despite these similarities in signalling mechanisms, metazoan Atg1 proteins appear to have gained additional functions relative to their yeast counterparts. For example, overexpression of Atg1 has been shown to inhibit TOR signalling in Drosophila larvae, and disruption of Atg1 in Drosophila or mammalian cells leads to increased TOR activ- Figure 1 The TOR pathway and autophagy regulation TOR complex 1, minimally comprising TOR, Lst8 and raptor (regulatory associated protein of TOR), regulates rapamycin-sensitive processes in response to upstream cues mediated by the Rheb and Rag family of small GTPases. TOR suppresses autophagy induction in part by inhibiting the activity of the serine/threonine protein kinase Atg1 and its partner Atg13, and by preventing recruitment of the class III PI3K Vps34 to autophagic membranes. Atg1 and Vps34 complexes are required for early steps of autophagosome nucleation and expansion. Vps34 also has an indirect role in subsequent vesicle fusion events (broken arrow), which is not rate-limiting for autophagy progression. Normal induction of autophagy also requires the serine/threonine protein kinase S6K, which is positively regulated through direct phosphorylation by TOR. Feedback signalling from S6K and Atg1 (grey arrows) result in self-limiting and amplifying effects respectively. ity, as measured by changes in S6K (p70 ribosomal protein S6 kinase) phosphorylation [20, 22] . These effects of Atg1 are indicative of a self-reinforcing feedback loop between Atg1 and TOR, which may serve to amplify and stabilize initially small changes in nutrient signalling (Figure 1 ). To take another example, murine Ulk1 plays a role in neurite outgrowth through effects on Rab5-dependent endocytic trafficking [23] . Consistent with such an extra-autophagic function, Drosophila Atg1 and Atg13 mutant animals do not survive to adulthood, whereas fruitflies carrying mutations in other Atg genes that disrupt autophagy to a similar extent are viable [5, 24] . Thus Atg1 complexes may have adapted to provide increased regulation and other functions to meet the demands of multicellularity.
Vps (vacuolar protein sorting) 34: a PI3K (phosphoinositide 3-kinase) with multiple roles in autophagy
The class III PI3K Vps34 represents a second potential target for autophagy regulation by TOR. This kinase generates the monophosphorylated lipid PtdIns3P, which acts to recruit PX (Phox homology) and FYVE domain-containing proteins to membrane compartments [25, 26] . The enzymatic activity of Vps34 is inhibited by the compound 3-methyladenine, a commonly used autophagy inhibitor. Vps34 potentially acts at a number of steps in autophagy. First, a complex comprising Vps34, Vps15, Atg6 and Atg14 in yeast (and Vp34, Vps15, the Atg6 orthologue Beclin1, the WD domain protein Ambra1 and the endophilin Bif-1 in mammals) is essential for an early nucleation step in autophagosome formation [4] . Secondly, a distinct Vps34 complex may function at a later step in the autophagy pathway in metazoan cells, in which autophagosomes must fuse with late endocytic vesicles to gain competency for lysosomal fusion [27] . Vps34 promotes the proper localization and assembly of components of the ESCRT (endosomal sorting complex required for transport), which acts in multivesicular endosome formation and is essential for autophagosome-lysosome fusion [28, 29] . Thirdly, human Vps34 has been found to promote TOR activity in response to amino acid and calcium levels, which should lead to autophagy inhibition [30] [31] [32] . These conflicting roles of Vps34 suggest that distinct pools of Vps34 may be regulated in opposite ways by nutrients.
We recently addressed these potential Vps34 functions through genetic and biochemical studies in Drosophila [33] . Null mutations in Vps34 were found to cause a strong block in starvation-induced autophagy in the larval fat body, resulting largely from a disruption of autophagosome biogenesis. In contrast, genetic disruption of the ESCRT leads to accumulation of autophagosomes, indicative of defective fusion. In cells doubly mutant for Vps34 and ESCRT components, formation and fusion of autophagosomes are both deficient, resulting in their gradual accumulation under both fed and starved conditions. These and additional genetic results indicate that the primary function of Vps34 in autophagy is early in autophagosome formation, probably in conjunction with Vps15 and Atg6/Beclin1, and that its endocytic functions are not rate-limiting for autophagy.
How is the activity of Vps34 linked to a cell's nutrient status to promote autophagy under appropriate conditions? In most cell types, Vps34 activity is concentrated at the early endocytic compartment. In Drosophila fat body cells, starvation causes a striking redistribution of PtdIns(3)P pools from Rab5-positive early endosomes to Atg8-positive nascent autophagosomes [33] . Interestingly, this starvationinduced shift in Vps34 activity requires both reduced TOR activity and wild-type Atg1 function (Figure 1) , implicating Vps34 as a downstream target of TOR-Atg1 signalling.
In contrast with the case in cultured mammalian cells, Vps34 mutants were found to have no effect on TOR activation in vivo in Drosophila [33] . Growth of Drosophila Vps34 mutant cells is indistinguishable from that of wildtype, both in mitotic and endoreplicative tissues, and under both growth-promoting and -inhibitory conditions. Phosphorylation of the TOR-dependent site on dS6K (Drosophila S6K) is also unaffected by Vps34 activity. These results may point to fundamental differences in mechanisms of nutrient-TOR signalling between fruitflies and mammals, or may reflect differences in TOR activation in cultured cells compared with the case in vivo. Recent identification of Rags (Ras-related GTPases) as transducers of nutrient signals to TOR in both Drosophila and mammalian systems indicates that this critical aspect of TOR activation is conserved [34, 35] .
S6K: putting on the brakes
Although autophagy is generally considered a beneficial process that promotes cell survival, high levels of autophagy are capable of causing cell death in some cases, e.g. in response to overexpression of Atg1 or activated Atg6/Beclin1. In Drosophila, starvation-induced autophagy peaks approx. 4 h after food withdrawal, and falls to a steady-state level that can be maintained for 2-3 weeks [16] . Similarly, Bax/Bakdeficient IL-3 (interleukin 3)-dependent cells can survive on intracellular nutrients generated through autophagy for several weeks [36] . What safeguards prevent autophagy from reaching harmful levels, while still allowing a sustained induction in response to starvation? Although the nutrients generated by autophagy potentially result in an intrinsic negative feedback, are there dedicated signalling mechanisms that function to keep this process in check even in the presence of inductive cues?
Findings from Drosophila and mammalian systems indicate that S6K may play such a role. Whereas S6K acts as positive mediator of TOR functions such as cell growth, its role in autophagy runs counter to that of the rest of the TOR pathway. Rather than inhibiting autophagy, S6K has been shown to be required for normal levels of starvation-induced autophagy. In Drosophila, S6K −/− fat body cells are deficient for autophagy induction in response to starvation or TOR mutation [16] . Similarly, simultaneous knockdown of mammalian S6K1 and S6K2 prevents autophagy induction [17] . One effect of this positive requirement for S6K is to limit the magnitude of autophagy in response to TOR down-regulation, due to the resulting down-regulation of S6K. In the Drosophila fat body, expression of activated S6K can increase the rate of autophagy in cells experiencing chronic TOR inactivation, but not in cells undergoing short-term starvation, indicating that S6K activity becomes limiting in the former case. By coupling a factor essential for autophagy to a negative regulator in this way, the chances of autophagy reaching damaging levels are reduced.
By what mechanisms does S6K promote autophagy? The requirement for S6K may simply reflect its role as a positive regulator of translation initiation, since protein synthesis is known to be required for normal expansion and maturation of autophagosomes [37, 38] . Alternatively, S6K-dependent signalling to components of the Atg machinery or other signalling pathways may be required for a normal autophagic response. For example, S6K can negatively regulate insulin signalling through feedback phosphorylation of IRS1 (insulin receptor substrate 1) [39, 40] . Induction of autophagy in response to TOR/S6K down-regulation may therefore be limited by a concomitant increase in insulin signalling, which inhibits autophagy induction. S6K may also participate directly in the regulation of more proximal autophagy regulators such as Atg1-Atg13 or Atg6-Vps34 complexes.
Perspectives and conclusions
Given the leading role TOR plays in autophagy regulation, and the important functions of autophagy in maintaining nutrient balance and cellular renewal, it is likely that autophagy makes a significant contribution to the physiological effects of TOR signalling. Indeed, the effects of rapamycin on cell growth and neurodegeneration have recently been shown to be partially dependent on autophagy [20, 41] . Similarly, the beneficial effects of reduced TOR signalling on lifespan in Caenorhabditis elegans are prevented in autophagy mutants [42] . The identification of Atg6/Beclin1 as a haploinsufficient tumour-suppressor gene is also in keeping with autophagy contributing to the effects of TOR on cancer development and progression [43, 44] . Although the ways in which autophagy influences these processes are poorly defined, these findings support the concept that autophagy represents a potential therapeutic target for a number of pathological conditions. In this regard, it may prove beneficial to develop treatments that directly modulate autophagy-related outputs of TOR signalling, while leaving other TOR outputs intact. Increased understanding of the signalling mechanisms underlying TOR-dependent autophagy regulation will aid in the development of such therapies.
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